Titlebook: Lipodystrophy Syndrome in HIV; Christine A. Wanke,Sherwood L. Gorbach Book 2003 Springer Science+Business Media New York 2003 Epidemiology

防銹

ugh great progress has been made in understanding epidemiology and etiology of the syndrome, much about the syndrome remains mysterious. It was our intention to assist HIV providers with a framework for understanding the status and complexities ofthe field. Each author was requested to provide an ev

倔強(qiáng)一點(diǎn)

Book 2003progress has been made in understanding epidemiology and etiology of the syndrome, much about the syndrome remains mysterious. It was our intention to assist HIV providers with a framework for understanding the status and complexities ofthe field. Each author was requested to provide an evidence-bas

托運(yùn)

outskirts

packet

overbearing

Epidemiology of Fat Redistribution in HIV,sometimes progressed so rapidly with abdominal discomfort that physicians were led to pursue intra-abdominal pathology. Not just common obesity, it was recognized as a distinct entity because it sometimes proceeded concurrently with marked atrophy of the face, buttocks, and extremities (.). Unusual

搬運(yùn)工

Body Composition in HIV Lipodystrophy, (visceral obesity, buffalo hump, lipomatosis, and breast enlargement), and regional fat loss (face, buttocks, appendices, and subcutaneous abdominal fat) (Table 1). Although a variety of terms have been used to describe these changes in the aggregate, there is as yet no consensus case definition or

antiandrogen

Methods for Assessing Body Composition in HIV-Associated Lipodystrophy,d individuals learned to apply the concepts of nutritional assessment, monitoring, and support. Early efforts concentrated on AIDS-wasting, which was characterized mainly as a loss of lean tissue, particularly the body cell mass, with variable loss of fat. Wasting was found to be common, often sever

byline

陪審團(tuán)

Abnormalities in Lipid Metabolism in HIV, and reduced low-density lipoprotein cholesterol and high-density lipoprotein cholesterol levels. These alterations become more evident with disease progression. However, over the last four years it has been shown that treatment of HIV infection with antiretroviral therapy including one or more prot